Litšobotsi tsa Ts'ebetso
Moeli oa ho lemoha: 5ng / mL;
Linear Range: 5.00~400.00 ng / mL;
Linear coefficient coefficient R ≥0.990;
Ho nepahala: ka har'a batch CV ke ≤15%;pakeng tsa lihlopha CV ke ≤20%;
Ho nepahala: kheloha e lekanyelitsoeng ea liphetho tsa tekanyo e ke ke ea feta ± 15% ha calibrator e tloaelehileng ea ho nepahala e lekoa.
1. Boloka sesupa-buffer ho 2~30℃.Buffer e tsitsitse ho fihlela likhoeling tse 18.
2. Store Aehealth Ferritin Rapid Quantitative test cassette ho 2~30℃, shelf bophelo ba ho fihla ho 18 months.
3. Cassette ea teko e lokela ho sebelisoa nakong ea hora e le 'ngoe ka mor'a ho bula pakete.
ST2 ke setho sa Toll-like receptor/interleukin-1 (interleukin-1, IL-1) receptor superfamily.IL-33 ke ligand ea eona e sebetsang hantle 'me e hlahisoa ke cardiomyocytes le fibroblasts.Lihlahisoa tse peli tsa liphatsa tsa lefutso: transmembrane ST2 (ST2L) le sST2.ST2L e na le likarolo tse tharo tsa extracellular immunoglobulin, ha sST2 e haelloa ke transmembrane le intracellular receptor domains.Li tlama ho ligand tse tloaelehileng tsa IL-33 'me li bapala karolo ea likokoana-hloko.Tsela ea matšoao ea ST2L le IL-33 e na le liphello tse sireletsang pelo tse kang anti-cardiomyocyte hypertrophy, myocardial fibrosis le anti-atherosclerosis.Ha boima ba pelo bo ntse bo eketseha, tlhahiso ea sST2 e eketseha, 'me sST2 e eketsehileng e thibela IL-33 ho kopana le ST2L, kahoo e hanyetsa phello ea pelo ea IL-33 / ST2L ea tsela ea pontšo.Ho nahanoa hore sST2 e kanna ea ba mokena-lipakeng oa pathogenic oa cardiomyocyte hypertrophy le myocardial fibrosis.Boikemisetso bo bongata ba maemo a sST2 bo ka fa lingaka sesebelisoa se nepahetseng ho thusa tlhahlobo ea ho hloleha ha pelo.